InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-24.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Favet Michael, Chairman & CEO. Insider active across 1 company, notably NeuroPace Inc. Aggregated, 6 reports have been logged. History available since 4 June 2021. The latest transaction was filed on 21 February 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations6 total
225,000 shares0Common StockSEC:0001209191-23-011945:0
155,080 shares0Common StockSEC:0001209191-22-017119:0
27,000 shares0Common StockSEC:0001209191-21-043744
27,000 shares0Common StockSEC:0001209191-21-043744:0
26,590 shares0Common StockSEC:0001209191-21-038994:0
26,590 shares0Common StockSEC:0001209191-21-038994
6 of 6 declarations
About Favet Michael
Michael Favet is Chief Executive Officer of NeuroPace Inc. He leads the company with a strategic vision, overseeing operations and the development of innovative products in the medical technology field.
